- Health Conditions
- Events
- Ask a Doctor
- Visit A Doctor
- HCP Portal
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: pfizer
Pfizer is discontinuing its sickle cell disease treatment Oxbryta and withdrawing from markets approved due to risks of painful vaso-occlusive crisis and deaths seen in clinical trials, which found 8 deaths in those taking the drug vs 2 in placebo.
Log In or Register as a healthcare professional to read the full article.
The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.
Pfizer’s (RSV) vaccine has shown promising results in protecting infants and older adults from the illness caused by this virus. Read more.
The COVID-19 disease is a contagious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known…
Pfizer and BioNTech, makers of the COVID-19 mRNA vaccines, held a press release on Wednesday (8 Dec), saying that the…
Subscribe to Updates
Subscribe to receive latest health related news from us
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.